Calidi Biotherapeutics: Funding, Investors & Team (Sep 2026)
Calidi Biotherapeutics is a company specializing in developing immunotherapies using oncolytic viruses to treat challenging cancers. The company's patented technology enables targeted delivery of these viruses, providing healthcare professionals with cutting-edge cancer treatment options.
Calidi Biotherapeutics has raised $45.1M across 8 funding rounds on record, the most recent an undisclosed round of $4.6M announced in Jul 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Calidi Biotherapeutics Company Profile and Key Stats
Latest funding round on record: Jul 2025.
Calidi Biotherapeutics Funding Rounds
Calidi Biotherapeutics raised $3.1M in an undisclosed round announced in Dec 2022.
6 months later, a Series B of $25.0M was announced in Jun 2023.
3 months later, an undisclosed round of $2.0M was announced in Sep 2023.
6 months later, an undisclosed round of $200k was announced in Mar 2024.
7 months later, an undisclosed round of $2.0M was announced in Oct 2024.
3 months later, an undisclosed round of $4.3M was announced in Jan 2025.
2 months later, an undisclosed round of $3.9M was announced in Mar 2025.
4 months later, an undisclosed round of $4.6M was announced in Jul 2025.
Calidi Biotherapeutics Founders and Leadership Team
Contact details for the Calidi Biotherapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Calidi Biotherapeutics Funding Compared to Other Biotechnology Startups
Calidi Biotherapeutics' latest round of $4.6M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Calidi Biotherapeutics in Biotechnology and San Diego
Companies Similar to Calidi Biotherapeutics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Calidi Biotherapeutics Funding FAQs
What does Calidi Biotherapeutics do?
Calidi Biotherapeutics is a company specializing in developing immunotherapies using oncolytic viruses to treat challenging cancers. The company's patented technology enables targeted delivery of these viruses, providing healthcare professionals with cutting-edge cancer treatment options.
How much funding has Calidi Biotherapeutics raised?
Calidi Biotherapeutics has raised $45.1M across 8 rounds on record. The most recent is an undisclosed round of $4.6M announced in Jul 2025.
When did Calidi Biotherapeutics last raise funding?
Calidi Biotherapeutics' most recent funding round on record is an undisclosed round of $4.6M, announced in Jul 2025.
Who founded Calidi Biotherapeutics?
FundedIQ lists Allan Camaisa (Founder) at Calidi Biotherapeutics.
Where is Calidi Biotherapeutics headquartered?
Calidi Biotherapeutics is based in San Diego, California, United States.
How many employees does Calidi Biotherapeutics have?
Calidi Biotherapeutics is in the 11-50 employee band.
How does Calidi Biotherapeutics' funding compare to other Biotechnology startups?
Calidi Biotherapeutics' latest round of $4.6M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Calidi Biotherapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Calidi Biotherapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.